Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

Clinical trial NCT06304883 · TERMINATED

Trial details

NCT number: NCT06304883
Sponsor: Alzheon Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Early Alzheimer's Disease

Start date: 2024-04-02
Primary completion: 2026-03-11
Enrollment: 163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.